LncRNA CASC2 Alleviates Renal Interstitial Inflammation and Fibrosis through MEF2C Downregulation-Induced Hinderance of M1 Macrophage Polarization

被引:0
|
作者
Hu, Jinping [1 ]
Zhang, Xiaoyan [2 ]
Ma, Feng [1 ]
Huang, Chen [2 ]
Jiang, Yali [2 ]
机构
[1] Xi An Jiao Tong Univ, HongHui Hosp, Dept Nephrol, Xian, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
LncRNA CASC2; MEF2C; Renal interstitial fibrosis; M1 macrophage polarization; Macrophages; MIGRATION INHIBITORY FACTOR; TGF-BETA; MYOFIBROBLASTS; EXPRESSION; REGENERATION; MECHANISMS; ORIGIN; MATRIX;
D O I
10.1159/000531919
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Long noncoding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) alleviates the progression of diabetic nephropathy by inhibiting inflammation and fibrosis. This study investigated how CASC2 impacts renal interstitial fibrosis (RIF) through regulating M1 macrophage (M1) polarization. Method: Nine-week-old mice underwent unilateral ureteral obstruction (UUO) establishment. Macrophages were induced toward M1 polarization using lipopolysaccharide (LPS) in vitro and cocultured with fibroblasts to examine how M1 polarization influences RIF. LnCeCell predicted that CASC2 interacted with myocyte enhancer factor 2 C (MEF2C), which was validated by dual-luciferase reporter assay. CASC2/MEF2C overexpression was achieved by lentivirus-expressing lncRNA CASC2 injection in vivo or CASC2 and MEF2C transfection in vitro. Renal injury was evaluated through biochemical analysis and hematoxylin-eosin/Masson staining. Macrophage infiltration and M1 polarization in the kidney and/or macrophages were detected by immunofluorescence, flow cytometry, and/or quantitative reverse transcription polymerase chain reaction (qRT-PCR). Expressions of CASC2, MEF2C, and markers related to inflammation/M1/fibrosis in the kidney/macrophages/fibroblasts were analyzed by qRT-PCR, fluorescence in situ hybridization, enzyme-linked immunosorbent assay, and/or Western blot. Result: In the kidneys of mice, CASC2 was downregulated and macrophage infiltration was promoted time-dependently from days 3 to 14 post-UUO induction; CASC2 overexpression alleviated renal histological abnormalities, hindered macrophage infiltration and M1 polarization, downregulated renal function markers serum creatinine and blood urea nitrogen and inflammation/M1/fibrosis-related makers, and offset UUO-induced MEF2C upregulation. LncRNA CASC2 overexpression inhibited fibroblast fibrosis and M1 polarization in cocultured fibroblasts with LPS-activated macrophages. Also, CASC2 bound to MEF2C and inhibited its expression in LPS-activated macrophages. Furthermore, MEF2C reversed the inhibitory effects of lncRNA CASC2 overexpression. Conclusion: CASC2 alleviates RIF by inhibiting M1 polarization through directly downregulating MEF2C expression. CASC2 might represent a promising value of future investigations on treatment for RIF.
引用
收藏
页码:245 / 263
页数:19
相关论文
共 50 条
  • [11] LncRNA MIR4435-2HG suppression regulates macrophage M1/M2 polarization and reduces intestinal inflammation in mice with ulcerative colitis
    Cao, Li
    Tan, Qinghai
    Zhu, Rui
    Ye, Lanxiang
    Shi, Gaiping
    Yuan, Zhenglin
    CYTOKINE, 2023, 170
  • [12] High glucose promotes macrophage M1 polarization through miR-32/Mef2d/cAMP signaling pathway
    Chen, Cong
    Cao, Jingsong
    Gao, Yan
    Xie, Xiaoping
    Zhao, Zhibo
    Yuan, Qing
    He, Yuqi
    Zu, Xuyu
    Liu, Jianghua
    GENES & DISEASES, 2024, 11 (02) : 539 - 541
  • [13] Fermented Cordyceps Powder alleviates silica-induced inflammation and fibrosis by inhibiting M1 macrophage polarization via the HMGB1-TLR4-NF-κB pathway
    Pu, Shuangshuang
    Meng, Xiangjing
    Shi, Yushan
    Huang, Ning
    Zhang, Chunlai
    Pang, Aimei
    Shao, Hua
    Jia, Qiang
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 345
  • [14] LncRNA NRON promotes M2 macrophage polarization and alleviates atrial fibrosis through suppressing exosomal miR-23a derived from atrial myocytes
    Li, Jianan
    Zhang, Qingchun
    Jiao, Haimiao
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (07) : 1512 - 1519
  • [15] Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl4/2-AAF
    Xu, Ying
    Xu, Wen
    Liu, Wei
    Chen, Gaofeng
    Jiang, Shili
    Chen, Jiamei
    Jian, Xun
    Zhang, Hua
    Liu, Ping
    Mu, Yongping
    PHARMACEUTICAL BIOLOGY, 2021, 59 (01) : 1150 - 1160
  • [16] Dihydromyricetin-Encapsulated Liposomes Inhibit Exhaustive Exercise-Induced Liver Inflammation by Orchestrating M1/M2 Macrophage Polarization
    Zhou, Xi
    Yi, Long
    Lang, Hedong
    Zhang, Jun
    Zhang, Qianyong
    Yu, Li
    Zhu, Jundong
    Mi, Mantian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [17] METTL3-mediated TIM1 promotes macrophage M1 polarization and inflammation through IGF2BP2-dependent manner
    Du, Xianrong
    Guo, Yinguang
    Zhao, Xiaoqin
    Zhang, Lijuan
    Fan, Ru
    Li, Yafeng
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (10)
  • [18] LPS-induced systemic inflammation is suppressed by the PDZ motif peptide of ZO-1 via regulation of macrophage M1/M2 polarization
    Lee, Hyun-Chae
    Park, Sun-Hee
    Jeong, Hye Min
    Shin, Goeun
    Lim, Sung In
    Kim, Jeongtae
    Shim, Jaewon
    Park, Yeong-Min
    Song, Kyoung Seob
    ELIFE, 2024, 13
  • [19] Macrophage A2aR Alleviates LPS-Induced Vascular Endothelial Injury and Inflammation via Inhibiting M1 Polarisation and Oxidative Stress
    Li, Yanxiu
    Chen, Tingzhen
    Cheang, Iokfai
    Liu, Peiben
    Zhao, Lin
    He, Xiaoxin
    Jin, Yuxi
    Tang, Mingmin
    Zhang, Zhongqi
    Sheng, Chengyu
    Zhang, Zhongwen
    Zuo, Xiangrong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (05)
  • [20] Wutou decoction attenuates the synovial inflammation of collagen-induced arthritis rats via regulating macrophage M1/M2 type polarization
    Lin, Weiji
    Shen, Pan
    Huang, Ying
    Han, Liang
    Ba, Xin
    Huang, Yao
    Yan, Jiahui
    Li, Tingting
    Xu, Lijun
    Qin, Kai
    Chen, Zhe
    Tu, Shenghao
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 301